Chemicals and pharmaceuticals

INTERCEPT PHARMACEUTICALS, INC.

29 filings mentioning 8 of the compliance and risk topics we track, most recently 2023-11-08. Every row links to the filing on EDGAR.

Page built . This page is derived from the framework corpus, which changes when the corpus is extended rather than daily.

29filings we hold
8topics disclosed
Chemicals and pharmaceuticalsindustry
NJbased in

Across 29 filings we hold, INTERCEPT PHARMACEUTICALS, INC. has written down 8 of the topics we track. That places it 77 of 755 companies we hold in chemicals and pharmaceuticals, by how much we have collected.

INTERCEPT PHARMACEUTICALS, INC. has written 8 of our tracked topics into its filings. What it disclosed is public. What that now obligates is not, and it is 530 controls.From SEC filings and our framework corpus

What it discloses

Tracked topics appearing in this company's filings, most frequent first. Each opens the topic, where you can see who else files it and what it obligates.

Ransomware23
Material Weakness4
Internal Control3
Enforcement Action2
Consent Order2
Restatement1
Regulatory Reporting1
Business Continuity1
TopicFilingsMost recent
Ransomware232023-11-06
Material Weakness42023-09-26
Internal Control32023-09-26
Enforcement Action22023-03-24
Consent Order22021-08-23
Restatement12023-11-08
Regulatory Reporting12022-08-03
Business Continuity12021-07-29

What this obligates

Every instrument below governs something INTERCEPT PHARMACEUTICALS, INC. has written into a filing. This maps to obligations within those frameworks. It is not a finding that the company has failed any of them, and nothing here establishes noncompliance.

ISO 27001:2013114
ISO 27001:2022112
NIST Cybersecurity Framework 2.0106
ISO 22301:201949
ISO 37001:201639
ASD Strategies to Mitigate Cyber Security Incidents37
ISO 3700126
COSO Internal Control23
US Foreign Corrupt Practices Act (FCPA)18
Basel III International Banking Framework6

10 frameworks, 530 controls between them, deduplicated across topics.

And what those same controls reach into

The controls behind those frameworks also appear in the instruments below, which suggests increased attention to them follows from the same work rather than from a separate programme.

ISO 27701:2019726
ISO 27002:2022610
ISO/IEC 42001:2023387
NIS2 Directive201
PCI DSS 4.0186
COBIT 2019170
ISO 9001:201553
ISO 22000:201847

Tell me when INTERCEPT PHARMACEUTICALS, INC. files something new

One email when there is a new SEC filing, naming what it is and what our corpus says it puts in scope. Nothing else, and one click to stop.

When it filed

Filings we hold, by year. Hover a bar for the count. Peak 11 in 2022.

19
20
21
22
23

Recent filings

FiledFormItem
2023-11-088-KEntry into a material agreement, Completion of an acquisition, Item 2.04filing
2023-11-0610-Qfiling
2023-09-268-KEntry into a material agreement, Other material event, Financial statements and exhibitsfiling
2023-08-028-KResults of operations, the earnings release, Financial statements and exhibitsfiling
2023-08-0210-Qfiling
2023-04-278-KResults of operations, the earnings release, Financial statements and exhibitsfiling
2023-04-2710-Qfiling
2023-03-248-KEntry into a material agreement, Other material event, Financial statements and exhibitsfiling
2023-03-028-KResults of operations, the earnings release, Financial statements and exhibitsfiling
2023-03-0210-Kfiling
2022-11-018-KResults of operations, the earnings release, Financial statements and exhibitsfiling
2022-11-0110-Qfiling

Others in chemicals and pharmaceuticals

The companies we hold most on in the same industry classification. Each opens side by side with this one.

CompanyFilings
ATNF180 Life Sciences Corp.34compare →
TSVT2seventy bio, Inc.8compare →
SXTP60 DEGREES PHARMACEUTICALS, INC.8compare →
ETNB89bio, Inc.17compare →
AARDAardvark Therapeutics, Inc.7compare →
ABTABBOTT LABORATORIES7compare →

Where this goes next

  1. The topic INTERCEPT PHARMACEUTICALS, INC. files on most, and every other company that files on it:Ransomware →
  2. How the rest of chemicals and pharmaceuticals compares, and who files most:Chemicals and pharmaceuticals →
  3. The failures that these disclosures usually turn out to be:How compliance programmes fail →
  4. What moved across every company we hold this week:What changed →
  5. And how much of any framework you are already carrying without knowing:What you already have →
New here? Signals tracks the compliance and risk language public companies put into their SEC filings, and cross-references it against 723 frameworks and 20,473 controls. See what moved today or check how much of a framework you already cover.

What this page is

Every row comes from SEC full-text search over this company's filings, matched against the compliance and risk phrases we track. It is a record of what the company itself wrote down, in documents it is legally accountable for. It is not an assessment of the company, a rating, or a claim about how well it manages anything.

A phrase appearing in a filing frequently means the risk section mentions it, not that an event occurred. Where an item number indicates an actual event, the Item column says so.

All of chemicals and pharmaceuticals · All companies · Today's edition